Marpai

Marpai, Inc. offers a SMART health plan services system that transforms health plan into a health empowerment tool. It provides health plan services system addresses the problems of healthcare. The firm uses deep learning, artificial intelligence, to empower people to live better, stay strong and spend less on healthcare. Its SMART health plan services enables companies to provide better healthcare to employees and significantly reduce administration, reinsurance and care costs. The company was founded in January 2021 and is headquartered in Tampa, FL.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Marpai shifts focus to high-margin clients, improves financial metrics

Marpai's Q1 2024 performance reflected a strategic focus on high-margin clients, leading to improved financial metrics despite a decrease in net revenues. With a strong balance sheet and recent capital actions, the company is well-positioned to pursue growth opportunities in the competitive TPA market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), a technology company using artificial intelligence (A.I.) to transform health plans for employers that self-fund their healthcare, today announced the closing of its previously announced public offering of 7,400,000 shares of its common stock at a public offering price of $1.00 per share, for gross proceeds of $7,400,000, before deducting underwriting discounts and offering expenses.

Marpai, Inc. Announces Closing of Public Offering

Marpai (NASDAQ: MRAI ) stock is taking a beating on Monday after the company announced a proposed public offering for its shares. Marpai announced the proposed public offering after markets closed on Friday.

Why Is Marpai (MRAI) Stock Down 40% Today?

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI) a technology company using artificial intelligence (A.I.) to transform health plans for employers that self-fund their healthcare, today announced the pricing of an underwritten public offering of 7,400,000 shares of its common stock at a public offering price of $1.00 per share, for gross proceeds of approximately $7,400,000, before deducting underwriting discounts and offering expenses.

Marpai, Inc. Announces Pricing of Public Offering

Inpixon

Exela Technologies

Use these tips to find rising penny stocks The post Finding Rising Penny Stocks, 3 Tips for Success appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Finding Rising Penny Stocks, 3 Tips for Success

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI) a technology company transforming the company health plan for employers that self-fund their healthcare, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. ThinkEquity is acting as the sole book-running manager for the offering.

Marpai, Inc. Announces Proposed Public Offering of Common Stock

Marpai, Inc. (NASDAQ:MRAI ) Q4 2023 Earnings Conference Call March 30, 2023 8:30 AM ET Company Participants Edmundo Gonzalez - Co-Founder & CEO Yoram Bibring - CFO Simon Li - Corporate VP & Co-Founder Conference Call Participants Allen Klee - Maxim Group Operator Good day, and thank you for standing by. Welcome to the Marpai Fourth Quarter and Full-Year 2022 Earnings Conference Call.

Marpai, Inc. (MRAI) Q4 2022 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), a technology company transforming the company health plan for employers that self-fund their healthcare, today reported financial results for the fourth quarter and year ended December 31, 2022. The Company's consolidated results of operations include the results of operations of Marpai and its wholly owned subsidiary, Marpai Health, Inc., for all periods presented, and the results of Marpai Administrators LLC.

Marpai, Inc. Reports the Fourth Quarter and Year End 2022 Results

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. ("Marpai" or the “Company”) (Nasdaq: MRAI), a deep learning technology company transforming third-party administration (TPA) in the self-funded health insurance market, will host a conference call and webcast on Thursday, March 30 at 8:30 a.m. ET to answer questions about the Company's operational and financial highlights for its fourth quarter and the full year 2022.

Marpai to Host Call on March 30, 2023 to Discuss Fourth Quarter & Full Year 2022 Financial Results

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-powered Third-Party Administrator (TPA) transforming self-funded employer health plans, announces a relationship with Vori Health, Inc. (“Vori Health”) to offer innovative musculoskeletal (MSK) care to employer health plan members.

Marpai Partners with Vori Health to Offer Value-Based Musculoskeletal Care to Self-Funded Employer Health Plans

NEW YORK--(BUSINESS WIRE)--Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), the AI-technology company transforming self-funded employer health plans, introduces the myMarpai Medical Shopping Tool, which displays medical services pricing charged by healthcare providers connected to the employer's health plan.

Marpai Introduces Provider Price Transparency Tool for Health Plan Members

Marpai Hires Gonen Antebi as Chief Operating Officer

Marpai adds clinical solution focused on effectively managing chronic health conditions to improve health outcomes, trajectories and plan costs NEW YORK , Jan. 5, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-technology company transforming self-funded employer health plans, introduces Marpai Chronic Condition Management to improve the care journey of members with chronic conditions like heart disease, respiratory disease, diabetes, kidney disease and mental health. This is the latest addition to Marpai's Clinical Services Ecosystem – proven, clinical care solutions, backed by outcome and quality data, delivering specialized strategies and support to manage costly conditions.

Marpai Introduces Chronic Condition Management to Improve Outcomes for Employer Health Plan Members

Marpai adds proven diabetes leader to its Proactive Targeted Health Interventions service to improve outcomes for health plan members with diabetes NEW YORK , Nov. 16, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-technology company transforming self-funded employer health plans, announces the addition of Virta Health as a Premium Health Partner to improve health outcomes for health plan members with diabetes. Virta offers a breakthrough approach that has proven to reverse type 2 diabetes and other chronic metabolic diseases safely and sustainably and without the risks, costs, or side effects of medications or surgery.

Marpai Announces Virta as Diabetes Premium Health Partner

Marpai, Inc. (NASDAQ:MRAI ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Edmundo Gonzalez - Co-Founder, CEO, Secretary & Director Yoram Bibring - CFO Conference Call Participants Allen Klee - Maxim Group Operator Good day, and thank you for standing by. Welcome to the Marpai Second Quarter 2022 Earnings Conference Call in which management will also discuss the Maestro Health acquisition.

Marpai, Inc. (MRAI) Q3 2022 Earnings Call Transcript

NEW YORK , Nov. 9, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-technology company transforming the $22 billion Third-Party Administrator (TPA) market supporting self-funded employer health plans, today reported financial results for the third quarter ended September 30, 2022. The Company's consolidated results of operations include the results of operations of Marpai and its wholly owned subsidiary, Marpai Health, Inc., for all periods presented, and the results of Marpai Administrators, LLC (formerly Continental Benefits, LLC) since its acquisition on April 1, 2021.

MARPAI, INC. REPORTS THIRD QUARTER 2022 RESULTS

NEW YORK , Nov. 1, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a deep learning technology company transforming third-party administration (TPA) in the self-funded health insurance market, will host a conference call and webcast on Thursday, November 10 at 8:30 a.m. ET to answer questions about the Company's operational and financial highlights for its third quarter in 2022.

MARPAI TO HOST CALL ON NOVEMBER 10, 2022 TO DISCUSS THIRD QUARTER FINANCIAL RESULTS

New York, New York--(Newsfile Corp. - October 12, 2022) - Marpai, Inc. (NASDAQ: MRAI), an AI technology company leveraging deep learning and machine learning to transform the employer health plan market, will be participating in The ThinkEquity Conference, which will take place on October 26, 2022 at The Mandarin Oriental Hotel in New York. Edmundo Gonzalez will be presenting at 8:30 am ET on October 26th.

Marpai, Inc. Announces Participation in The ThinkEquity Conference

New innovative PBM lowers drug costs for self-insured health plans and makes it easy for members to find affordable medications NEW YORK , Aug. 25, 2022 /PRNewswire/ -- Marpai, Inc., ("Marpai") (Nasdaq: MRAI), an AI technology company transforming third-party administration (TPA) in the self-funded employer health plan market, announces a new pharmacy benefit management (PBM) solution available to current and potential clients nationwide called MarpaiRx. MarpaiRx is powered by a collaboration with MedOne Pharmacy Benefit Solutions ("MedOne").

Marpai Launches MarpaiRx Pharmacy Benefit Management Solution to Decrease Prescription Costs

OncoCyte

Summit Therapeutics

The Dow Jones dropped by around 170 points on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades.

OncoCyte And 2 Other Stocks Under $1 Insiders Are Aggressively Buying

Marpai, Inc. (NASDAQ:MRAI ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Simon Li – Vice President Edmundo Gonzalez – Chief Executive Officer, Secretary and Director Yoram Bibring – Chief Financial Officer Conference Call Participants Allen Klee – Maxim Group Operator Good day and thank you for standing by. Welcome to the Marpai Second Quarter 2022 Earnings Conference Call in which management will also discuss the Maestro Health acquisition.

Marpai, Inc. (MRAI) CEO Edmundo Gonzalez on Q2 2022 Results - Earnings Call Transcript

NEW YORK , Aug. 10, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-technology company transforming the $22 billion Third-Party Administrator (TPA) market supporting self-funded employer health plans, today reported financial results for the second quarter ended June 30, 2022. The Company's consolidated results of operations include the results of operations of Marpai and its wholly owned subsidiary, Marpai Health, Inc., for all periods presented, and the results of Marpai Administrators, LLC (formerly Continental Benefits, LLC) since its acquisition on April 1, 2021.

MARPAI, INC. REPORTS SECOND QUARTER 2022 RESULTS

Marpai announced it is buying Maestro Health for $22.1 million. This is why.

Why Marpai (MRAI) Is Buying Maestro Health For $22.1 Million

Approximately Doubling Its Size NEW YORK , Aug. 4, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-technology company transforming the $22 billion Third-Party Administrator (TPA) market supporting self-funded employer health plans, today announced it has signed a definitive agreement to acquire Maestro Health ("Maestro"), a leading TPA servicing over 80 self-insured employers, based in Chicago, Illinois.   Highlights of the transaction include: At the closing the combined company will serve over 40,000 employee lives with expected combined proforma annual revenues of approximately $40 million in 2022.

Marpai To Acquire Maestro Health

NEW YORK , Aug. 2, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a deep learning technology company transforming third-party administration (TPA) in the self-funded health insurance market, will host a conference call and webcast on Thursday, August 11 at 8:30 a.m. ET to answer questions about the Company's operational and financial highlights for its second quarter in 2022.

MARPAI TO HOST CALL ON AUGUST 11, 2022 TO DISCUSS SECOND QUARTER FINANCIAL RESULTS

Bestselling author and thought leader talks about re-designing health care with a focus on quality to the nation's top brokers and consultants convening at the Marpai Broker Retreat. NEW YORK , June 23, 2022 /PRNewswire/ -- Marpai, Inc., ("Marpai") (Nasdaq: MRAI), an artificial intelligence (AI)-technology company transforming the $22B Third-Party Administrator (TPA) market supporting self-funded employer health plans, featured Dr. Marty Makary as a keynote speaker at its second annual Broker Retreat held at the Four Seasons hotel in Ft.

News for Marpai Stock (MRAI)